A cross talk between the ErbB/HER family and IGF1R signaling pathway has been proven in breast cancer [11,12,13] and the evidences reported in this study supports the hypothesis that this mechanism could be also involved in this context. The gene discussed is EGFR; the disease is breast carcinoma.